α1-antitrypsin (AAT) deficiency and ANCA-positive systemic vasculitis: Genetic and clinical implications

European Journal of Clinical Investigation

Volumn 27, Issue 8, 1997, Pages 696-702

  Callea, Francesco ^a,g   Gregorini, G ^a   Sinico, A ^b   Gonzales, G ^c   Bossolasco, M ^c   Salvidio, G ^d   Radice, A ^b   Tira, P ^a   Candiano, G ^e   Rossi, G ^e   Petti, A ^f   Ravera, G ^f   Ghiggeri, G ^e   Gusmano, R ^e  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SAN CARLO BORROMEO HOSPITAL   (Italy)

^c Molecular Genetics   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e G GASLINI INSTITUTE   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g SPEDALI CIVILI   (Italy)

Author keywords

Antiproteinase 3 antibodies; Vasculitis; Wegener's granulomatosis

Indexed keywords

ADULT; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; AUTOIMMUNITY; CASE CONTROL STUDY; ENHANCER REGION; FEMALE; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REMISSION; SYSTEMIC VASCULITIS;

EID: 12644259501     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1720717.x     Document Type: Article

References (23)

1. Esnault VL, Testa A, Audrain M. Alpha-1-antitrypsin genetic polymorphism in ANCA positive systemic vasculitis. Kidney Int 1993;43:1329-32.
2. Elzouki AN, Segelmark M, Wieslander J, Eriksson S. Strong link between the alpha-1-antitrypsin PiZ allele and Wegener's granulomatosis. J Intern Med 1994;236:543-8.
3. Savige JA, Chang L, Daskalakis M. Doery J. Alpha-1-antitrypsin deficiency and anti-proteinase 3 antibodies in ANCA associated systemic vasculitis. Clin Exp Immunol 1995;101(Suppl. 1):56.
4. Hagen EC, Hiemstra PS, Daha MR, van der Woude FJ. Alpha-1-antitrypsin in Wegener's granulomatosis. Clin Exp Immunol 1995; 101(Suppl. 1):56.
5. Segelmark M, Elzouki AN, Wieslander J, Eriksson S. The PiZ gene of α-1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int 1995;48:844-50.
6. Jennette JC, Falk RJ, Andrassy K, Bacon BA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GC, Kallenberg CG, McCluskey RT, Sinico RA, Rees AI, Van Es LA, Waldherr R, Wiik A. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
7. DeRemee RA, McDonald TI, Harrison EG Jr, Coles DT. Wegener's granulomatosis. Anatomic correlates a proposed classification. Mayo Clin Proc 1976;5L:777-81.
8. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
9. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989;10(Suppl. 6):12-3.
10. Sinico RA, Pozzi C, Radiee A, Tincani A, Livecchi M, Rota S, Comotti C, Ferrario F, D'Amico G. Clinical significance of antineutrophil cytoplasmic autoantibodies with specificity for lactoferrin in renal diseases. Am J Kidney Dis 1993;22:253-60.
11. Callea F, Massi G, De Wolf Peeters C, Lievens C, Desmet VJ. Alpha-1-antitrypsin phenotypes in malignant lymphoma. J Clin Pathol 1982;35:1213-5.
12. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horm GT, Mullis KB, Erlich HA. Primer-direct enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-91.
13. Sergi C, Gonsalez G, Fabbretti G, Brisigotti M, Faa G, Costa V, Romeo G, Callea F. Immunohistochemical and genetic characterization of the M Cagliari α-1-antitrypsin molecule (M-like α-1-antitrypsin deficiency). Lab Invest 1994;70:130-3.
14. Morgan K, Scobie G, Kalsheker NA. Point mutation in a 3′ flanking sequence of the alpha-1-antitrypsin gene associated with chronic respiratory disease occurs in a regulatory sequence. Hum Mol Gen 1993;2:253-7.
15. Callea F, Fevery J, Massi G, Lievens C, De Groote J, Desmet VJ. Alpha-1-antitrypsin and its stimulation in the liver of PiMZ phenotype individuals. A 'recruitment secretory block' (R-SB) phenomenon. Liver 1984;4:325-37
16. Callea F, Fevery J, De Groote J, Desmet VJ. Detection of PiZ phenotype individuals by alpha-1-antitrypsin (AAT) immunohistochemistry in paraffin embedded liver tissue specimens. J Hepatol 1986;2:389-401.
17. Kalsheker NA, Hodgson IJ, Watkins GL, White JP, Morrison HM, Stockley RA. Deoxyribonucleic acid (DNA) polymorphism of the alpha-1-antitrypsin gene in chronic lung disease. Br Med J 1987;294:1511-4.
18. Poller W, Meissen C, Olek K. DNA polymorphisms of the alpha-1-antitrypsin gene region in patients with chronic obstructive pulmonary disease. Eur J Clin Invest 1990;20:1-7.
19. Morgan K, Scobie G, Kalsheker N. The characterization of a mutation of the 3′ flanking sequence of the alpha-1-antitrypsin commonly associated with chronic obstructive airways disease. Eur J Clin Invest 1992;22:134-7.
20. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
21. Perlmutter DH. The cellular basis for liver injury in α-1-antitrypsin deficiency. Hepatology 1991;13:172-85.
22. Callea F, Fabbretti G, Bonetti M, Brisigotti M, Desmet VJ. Alpha-1-antitrypsin deficiency. In Schmid R, Bianchi L, Gerok W. Maier KP editors. Extrahepatic manifestations in liver diseases. Lancaster (UK) Kluwer Academic Publishers 1993;315-30.
23. Ishibashi H, Shihata K, Okibo H, Kawamura KT, Yanase T. Distribution of alpha-1-antitrypsin in normal, granuloma and tumor tissue in rats. J Lab Clin Med 1978;91:576-83.